The role of IgG Fc receptors in antibody-dependent enhancement | Nature Reviews Immunology

Antibody-dependent enhancement (ADE) has been described as a mechanism that contributes to the pathogenesis of dengue virus infection. Limited evidence also suggests that it can also occur in other viral infections. Here, the authors explore the history of the ADE phenomenon, discuss the diversity of Fc effector functions and consider its potential relevance in the context of SARS-CoV-2 infection.

Subjects Translational immunology Viral infection Abstract Antibody-dependent enhancement (ADE) is a mechanism by which the pathogenesis of certain viral infections is enhanced in the presence of sub-neutralizing or cross-reactive non-neutralizing antiviral antibodies. In vitro modelling of ADE has attributed enhanced pathogenesis to Fcγ receptor (FcγR)-mediated viral entry, rather than canonical viral receptor-mediated entry. However, the putative FcγR-dependent mechanisms of ADE overlap with the role of these receptors in mediating antiviral protection in various viral infections, necessitat

related reading

• Fcγ receptors as regulators of immune responses | Nature Reviews Immunologynature.com
• Vaccine Adjuvants: Putting Innate Immunity to Workncbi.nlm.nih.gov
• What is Fc receptors? - Creative Diagnosticscreative-diagnostics.com
• A primer on machine learning in antibody engineeringabhishaike.com
• UGCG and the glycosphingolipid rheostat: a metabolic checkpoint governing immune activation and tumor immune evasion | Signal Transduction and Targeted Therapynature.com
• The trinity of COVID-19: immunity, inflammation and interventionnature.com
• Immune Regulation | People | Osaka University Immunology Frontier Research Centerifrec.osaka-u.ac.jp
• Interferon-alpha/beta receptor - Wikipediaen.wikipedia.org
• T cell receptors overview - Mini-review | Bio-Radbio-rad-antibodies.com
• Interleukin-6 Blockade as Rescue Therapy in Autoimmune Encephalitis - PMCncbi.nlm.nih.gov
• Neutrophils to the ROScue: Mechanisms of NADPH Oxidase Activation and Bacterial Resistancencbi.nlm.nih.gov
• Boosting therapeutic potency of antibodies by taming Fc domain functions | Experimental & Molecular Medicinenature.com